Other languages Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-04-26 am EDT			5-day change	1st Jan Change
1,507 ^INR	-0.89%		-1.07%	+19.62%

Apr. 23	Indian Equities End Higher for Third Straight Day, Lifted by Real Estate, IT Stocks	MT
Apr. 17	Sun Pharmaceutical Industries Limited Company Receives an Order Passed by Deputy Commissioner of State Tax, Ropar, Punjab	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indian Equities End Higher for Third Straight Day, Lifted by Real Estate, IT Stocks	Apr. 23
Los mercados de India cierran a la baja en medio de sentimientos tibios de los inversores -- Market Talk	Apr. 12
Indian Equities Close Lower on Friday As Hopes for US Rate Cute in June Fade	Apr. 12
Sun Pharmaceutical's Dadra, India Unit Gets 'Official Action Indicated' Status from US FDA	Apr. 12
INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes	Apr. 12
Bausch wins US appeal to block Alvogen generic of diarrhea drug	Apr. 11
Sun Pharmaceutical Industries Appoints Chief Information Officer	Apr. 04
Sun Pharmaceutical Industries Limited Announces Executive Changes	Apr. 03
Sun Pharmaceutical Industries Limited Announces Retirement of Sailesh Trambaklal Desai as Director	Mar. 29
Bourse Zurich: le SMI finit sous la barre des 11'600 points	Mar. 19
Bourse Zurich: le SMI à la peine, Partners Group plombe l'ambiance	Mar. 19
Bourse Zurich: ouverture en petite forme attendue	Mar. 19
Cosmo: feu vert pour la commercialisation du Winlevi aux antipodes	Mar. 19
Cosmo erhält Zulassung für Winlevi in Australien	Mar. 19
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	Mar. 19
Sun Pharmaceutical's Acne Drug Gets Approval in Australia	Mar. 19
Sun Pharmaceutical Industries Limited Announces Approval of Winlevi in Australia	Mar. 18
Upbeat Global Markets, Strong GDP Send Indian Equities to Record Closing High on Friday	Mar. 01
Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue	Feb. 29
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	Feb. 28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Other languages

Filters